Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

49.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.0K
Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

551
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
551
Retroviruses02:33

Retroviruses

14.4K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
14.4K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

6.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

594
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
594

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Applications and limitations of the passenger hypothesis for HIV reservoir persistence and cure.

Journal of virology·2025
Same author

Human Immunodeficiency Virus-Associated Differences in the Tumor Immune Microenvironment of Lung, Breast, and Prostate Cancers.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2025
Same author

A blind spot in HIV diagnosis guidelines?

AIDS (London, England)·2025
Same author

Persistent, sterile necrotizing granulomatous dermatitis following treatment of 20-year <i>Mycobacterium marinum</i> infection.

JAAD case reports·2025
Same author

Sustained antiviral response against <i>in vitro</i> HIV-1 infection in peripheral blood mononuclear cells from people with chronic myeloid leukemia treated with ponatinib.

Frontiers in pharmacology·2024
Same author

Characteristics of a transgender and gender-diverse patient population in Utah: Use of electronic health records to advance clinical and health equity research.

PloS one·2024

Related Experiment Video

Updated: Dec 22, 2025

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

8.2K

Senotherapeutics and HIV-1 Persistence.

Matthew A Szaniawski1, Adam M Spivak2

  • 1Division of Infectious Diseases, Department of Medicine, University of Utah School of Medicine, 30 North 1900 East, Room 4B319, Salt Lake City, UT, 84132, USA.

Current HIV/AIDS Reports
|May 2, 2020
PubMed
Summary
This summary is machine-generated.

Senotherapeutics, drugs targeting senescent cells, show promise for treating HIV-1 persistence and immune exhaustion. These agents interrupt pathways crucial for senescent cell survival, offering a new strategy for chronic viral infections.

Keywords:
EradicationHIVLatencyPersistenceSenescenceSenotherapeutics

More Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.2K
High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
07:18

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Published on: January 22, 2019

6.1K

Related Experiment Videos

Last Updated: Dec 22, 2025

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

8.2K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.2K
High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
07:18

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Published on: January 22, 2019

6.1K

Area of Science:

  • Immunology
  • Gerontology
  • Virology

Background:

  • HIV-1 infection can lead to immune exhaustion and cellular senescence.
  • Cellular senescence involves pathways targeted by novel pharmacologic agents called senotherapeutics.
  • Chronic HIV-1 infection and senescence are linked to viral persistence.

Purpose of the Study:

  • To review the potential of senotherapeutics in addressing HIV-1 persistence.
  • To explore how targeting senescent cells can combat HIV-1-associated immune exhaustion.

Main Methods:

  • Review of recent literature on senotherapeutics and HIV-1.
  • Analysis of pathways targeted by senotherapeutics in the context of HIV-1 infection.

Main Results:

  • Senescent cells may arise from HIV-1 infection, contributing to persistence.
  • Senotherapeutics target specific pathways essential for senescent cell survival.
  • These pathways influence the cellular microenvironment in chronic HIV-1 infection.

Conclusions:

  • Senotherapeutics offer a novel strategy for combating HIV-1 persistence.
  • Targeting cellular senescence may help manage HIV-1-associated immune exhaustion.
  • Further research into senotherapeutics is warranted for HIV-1 treatment.